Home » Kuwaiti Firm Launches Breast Cancer Panel, Exome Services; Plans Move into Pre-implantation Dx

Kuwaiti Firm Launches Breast Cancer Panel, Exome Services; Plans Move into Pre-implantation Dx

Jul 17, 2013
|
Monica Heger
Premium

Kuwaiti molecular diagnostics firm Genatak has begun offering a targeted hereditary breast cancer panel and exome sequencing services for patients with cancer, undiagnosed genetic disorders, and individuals looking to understand disease risk.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Related Articles

Jul 02, 2014

Exome Sequencing May Enhance Dx Yield of Mitochondrial Disease

Premium
May 28, 2014

Exome Sequencing, not WGS, May ID Causative Mutations in Vast Majority of Mendelian Disease

Premium
Mar 17, 2014

OncoDNA Chosen to Supply NGS-based Cancer Panels to Parts of the Middle East

Jul 21, 2014

Sequencing Uncovers Rare Variants Linked to Noonan Syndrome, Aids in Diagnosis

Oct 22, 2014

At ASHG, Researchers Discuss the Merits and Drawbacks of Panels Versus Exomes

Premium
Oct 22, 2014

Exome Sequencing Moves Beyond Anecdotes Toward Standard of Care for Rare Disorders

Premium

The Scan

This Week in Genome Research

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

To the Brink

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Just Like Your Old Pop

Researchers report that paternally inherited genes are more likely to be expressed in mice.

This Week in PNAS

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

What's Popular?

In Clinical Sequencing

  1. Baylor Aims to Boost Dx Rate, Discovery with 'Medical Exome,' Consenting Unsolved Cases for Research

    Premium

  2. Sequenom Posts 13 Percent Rise in Q4 Revenues, Reports Profitability for FY 2014

  3. FDA SEQC Study Shows RNA-seq is Reproducible for Relative Expression, Can ID New Splice Junctions

    Premium

  4. Emory Launches Medical Exome with Enhanced Coverage of Disease-Associated Genes

    Premium

  5. In NEJM, Lander Lauds Steps at FDA to Build New Regulatory Framework for Genomic Tests

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.